129 related articles for article (PubMed ID: 22743653)
21. HGAL is a novel interleukin-4-inducible gene that strongly predicts survival in diffuse large B-cell lymphoma.
Lossos IS; Alizadeh AA; Rajapaksa R; Tibshirani R; Levy R
Blood; 2003 Jan; 101(2):433-40. PubMed ID: 12509382
[TBL] [Abstract][Full Text] [Related]
22. Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.
Gutiérrez-García G; Cardesa-Salzmann T; Climent F; González-Barca E; Mercadal S; Mate JL; Sancho JM; Arenillas L; Serrano S; Escoda L; Martínez S; Valera A; Martínez A; Jares P; Pinyol M; García-Herrera A; Martínez-Trillos A; Giné E; Villamor N; Campo E; Colomo L; López-Guillermo A;
Blood; 2011 May; 117(18):4836-43. PubMed ID: 21441466
[TBL] [Abstract][Full Text] [Related]
23. HGAL inhibits lymphoma dissemination by interacting with multiple cytoskeletal proteins.
Jiang X; Lu X; Gentles AJ; Zhao D; Wander SA; Zhang Y; Natkunam Y; Slingerland J; Reis IM; Rabinovich B; Abdulreda MH; Moy VT; Lossos IS
Blood Adv; 2021 Dec; 5(23):5072-5085. PubMed ID: 34543391
[TBL] [Abstract][Full Text] [Related]
24. The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study.
Thieblemont C; Briere J; Mounier N; Voelker HU; Cuccuini W; Hirchaud E; Rosenwald A; Jack A; Sundstrom C; Cogliatti S; Trougouboff P; Boudova L; Ysebaert L; Soulier J; Chevalier C; Bron D; Schmitz N; Gaulard P; Houlgatte R; Gisselbrecht C
J Clin Oncol; 2011 Nov; 29(31):4079-87. PubMed ID: 21947824
[TBL] [Abstract][Full Text] [Related]
25. The efficacy of HGAL and LMO2 in the separation of lymphomas derived from small B cells in nodal and extranodal sites, including the bone marrow.
Younes SF; Beck AH; Ohgami RS; Lossos IS; Levy R; Warnke RA; Natkunam Y
Am J Clin Pathol; 2011 May; 135(5):697-708. PubMed ID: 21502424
[TBL] [Abstract][Full Text] [Related]
26. Nodal diffuse large B-cell lymphomas in children and adolescents: immunohistochemical expression patterns and c-MYC translocation in relation to clinical outcome.
Gualco G; Weiss LM; Harrington WJ; Bacchi CE
Am J Surg Pathol; 2009 Dec; 33(12):1815-22. PubMed ID: 19816150
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of immunohistochemistry-based markers and algorithms in immunochemotherapy-treated diffuse large B cell lymphoma patients.
Culpin RE; Sieniawski M; Angus B; Menon GK; Proctor SJ; Milne P; McCabe K; Mainou-Fowler T
Histopathology; 2013 Dec; 63(6):788-801. PubMed ID: 24117687
[TBL] [Abstract][Full Text] [Related]
28. BCL2 positive and BCL6 negative diffuse large B cell lymphoma patients benefit from R-CHOP therapy irrespective of germinal and non germinal center B cell like subtypes.
Jovanovic MP; Mihaljevic B; Jakovic L; Martinovic VC; Fekete MD; Andjelic B; Antic D; Bogdanovic A; Boricic N; Terzic T; Jelicic J; Milenkovic S
J BUON; 2015; 20(3):820-8. PubMed ID: 26214636
[TBL] [Abstract][Full Text] [Related]
29. Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma.
van Imhoff GW; Boerma EJ; van der Holt B; Schuuring E; Verdonck LF; Kluin-Nelemans HC; Kluin PM
J Clin Oncol; 2006 Sep; 24(25):4135-42. PubMed ID: 16943530
[TBL] [Abstract][Full Text] [Related]
30. [Primary gastrointestinal diffuse large B-cell lymphoma: an immunohistochemical and prognostic study of 90 cases].
Lin L; Min M; Bi CF; Wang XQ; Luo TY; Zhao S; Zhang WY; Liu WP
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):220-6. PubMed ID: 21615994
[TBL] [Abstract][Full Text] [Related]
31. Primary central nervous system diffuse large B-cell lymphoma shows an activated B-cell-like phenotype with co-expression of C-MYC, BCL-2, and BCL-6.
Li X; Huang Y; Bi C; Yuan J; He H; Zhang H; Yu Q; Fu K; Li D
Pathol Res Pract; 2017 Jun; 213(6):659-665. PubMed ID: 28552541
[TBL] [Abstract][Full Text] [Related]
32. miR-155 regulates HGAL expression and increases lymphoma cell motility.
Dagan LN; Jiang X; Bhatt S; Cubedo E; Rajewsky K; Lossos IS
Blood; 2012 Jan; 119(2):513-20. PubMed ID: 22096245
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical profile and fluorescence in situ hybridization analysis of diffuse large B-cell lymphoma in northern China.
Li T; Medeiros LJ; Lin P; Yin H; Littlejohn M; Im W; Lennon PA; Hu P; Jorgensen JL; Liang M; Guo H; Yin CC
Arch Pathol Lab Med; 2010 May; 134(5):759-65. PubMed ID: 20441508
[TBL] [Abstract][Full Text] [Related]
34. Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis.
Baecklund E; Natkunam Y; Backlin C; Iliadou A; Askling J; Ekbom A; Feltelius N; Klareskog L; Enblad G; Lossos IS; Levy R; Sundström C; Rosenquist R
Br J Haematol; 2008 Apr; 141(1):69-72. PubMed ID: 18324968
[TBL] [Abstract][Full Text] [Related]
35. HGAL, a germinal center specific protein, decreases lymphoma cell motility by modulation of the RhoA signaling pathway.
Jiang X; Lu X; McNamara G; Liu X; Cubedo E; Sarosiek KA; Sánchez-García I; Helfman DM; Lossos IS
Blood; 2010 Dec; 116(24):5217-27. PubMed ID: 20844236
[TBL] [Abstract][Full Text] [Related]
36. Usefulness of HGAL and LMO2 immunohistochemistry in the identification of follicular lymphomas of the non-gastric gastrointestinal tract.
Chapman-Fredricks J; Younes SF; Fan YS; Sandoval-Sus JD; Natkunam Y; Lossos IS
Appl Immunohistochem Mol Morphol; 2013 May; 21(3):200-4. PubMed ID: 22914613
[TBL] [Abstract][Full Text] [Related]
37. EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation.
Montes-Moreno S; Odqvist L; Diaz-Perez JA; Lopez AB; de Villambrosía SG; Mazorra F; Castillo ME; Lopez M; Pajares R; García JF; Mollejo M; Camacho FI; Ruiz-Marcellán C; Adrados M; Ortiz N; Franco R; Ortiz-Hidalgo C; Suarez-Gauthier A; Young KH; Piris MA
Mod Pathol; 2012 Jul; 25(7):968-82. PubMed ID: 22538516
[TBL] [Abstract][Full Text] [Related]
38. [Prevalence of germinal center B-cell-like and non-germinal center B-cell-like types of diffuse large B-cell lymphoma in Shanghai, China].
Chen Y; Chen H; Fu K; Zhu XZ; Irons R
Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):313-8. PubMed ID: 20654154
[TBL] [Abstract][Full Text] [Related]
39. Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.
Fu K; Weisenburger DD; Choi WW; Perry KD; Smith LM; Shi X; Hans CP; Greiner TC; Bierman PJ; Bociek RG; Armitage JO; Chan WC; Vose JM
J Clin Oncol; 2008 Oct; 26(28):4587-94. PubMed ID: 18662967
[TBL] [Abstract][Full Text] [Related]
40. Most primary central nervous system diffuse large B-cell lymphomas occurring in immunocompetent individuals belong to the nongerminal center subtype: a retrospective analysis of 31 cases.
Hattab EM; Martin SE; Al-Khatib SM; Kupsky WJ; Vance GH; Stohler RA; Czader M; Al-Abbadi MA
Mod Pathol; 2010 Feb; 23(2):235-43. PubMed ID: 19935644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
